ICON Public Limited Company
ICLR
Κατάταξη σε μετοχές
#1653
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Τιμή μετοχής
$168.25
Τελευταίος συγχρονισμός: 2026-10-16
Κεφαλαιοποίηση
$12.98B
Αλλαγή (1 ημέρα)
-3.93%
Αλλαγή (1 έτος)
-9.08%
Χώρα
IE
Εμπόριο ICON Public Limited Company (ICLR)
Κατηγορία
Healthcare
EPS για ICON Public Limited Company (ICLR)
EPS στις June 2026 TTM: $4.29
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της ICON Public Limited Company, το τρέχον EPS της εταιρείας (TTM) είναι $4.29. Στο τέλος του 2023, η εταιρεία είχε EPS $7.46, αύξηση σε σχέση με το EPS του 2022 που ήταν $6.20.
Ιστορικό EPS της ICON Public Limited Company από 2001 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $4.29 | -55.31% |
| 2024 | $9.60 | 28.69% |
| 2023 | $7.46 | 20.32% |
| 2022 | $6.20 | 171.93% |
| 2021 | $2.28 | -63.75% |
| 2020 | $6.29 | -8.18% |
| 2019 | $6.85 | 14.93% |
| 2018 | $5.96 | 14.62% |
| 2017 | $5.20 | 9.47% |
| 2016 | $4.75 | 16.42% |
| 2015 | $4.08 | 45.71% |
| 2014 | $2.80 | 65.68% |
| 2013 | $1.69 | 83.70% |
| 2012 | $0.92 | 142.11% |
| 2011 | $0.38 | -73.97% |
| 2010 | $1.46 | -9.32% |
| 2009 | $1.61 | 20.15% |
| 2008 | $1.34 | -31.28% |
| 2007 | $1.95 | 44.44% |
| 2006 | $1.35 | 486.96% |
| 2005 | $0.23 | -88.14% |
| 2004 | $1.94 | 25.16% |
| 2003 | $1.55 | 27.05% |
| 2002 | $1.22 | 25.77% |
| 2001 | $0.97 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| $18.62 | 334.03% |
US
|
|
| $5.65 | 31.70% |
US
|
|
| $-1.36 | -131.70% |
US
|
|
| - | - |
CN
|
|
| $5.09 | 18.65% |
US
|
